Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444 cases classified according to the updated Kiel classification

Leukemia & Lymphoma
J DieboldDennis D Weisenburger

Abstract

The purpose of this study was: to compare the survival of diffuse large B-cell lymphomas (DLBCL) stratified according to the up-dated Kiel classification. A retrospective study of a cohort of 1378 cases was organized in 1996 by the Non-Hodgkin's Lymphoma Classification Project, and the DLBCL were classified according to the updated Kiel classification. The distribution of the different types and subtypes was as follows: centroblastic (CB, 85.4%), composed of the polymorphic (CB-PM, 58.6%), monomorphic (CB-MM, 17.1%) and multilobated (CB-ML, 9.7%) subtypes; immunoblastic (IB, 11.2%), with (8.3%) or without (2.9%) plasmacytoid differentiation; and anaplastic large cell lymphoma (ALCL) of B-cell type (3.4%). The rate of diagnostic agreement between pathologists was 78% for CB and 65% for IB lymphoma. The 5-year overall survival (OAS) for the entire group was 47% and the 5-year failure-free survival (FFS) was 42%. No significant differences in survival were found between the three major groups (CB, IB, ALCL). However, the 5-year OAS and FFS of patients with DLBCL not containing immunoblasts (CB-MM+CB-ML) was 51 and 52%, respectively, and was significantly better than the survival of those containing immunoblasts (CB-PM+IB+ALCL), wh...Continue Reading

References

Feb 6, 1988·Lancet·A G StansfeldO Mioduszewska
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J O Armitage, D D Weisenburger
Sep 18, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J R AndersonD D Weisenburger

❮ Previous
Next ❯

Citations

Oct 23, 2013·Current Hematologic Malignancy Reports·Hans Michael Kvasnicka
Feb 3, 2005·Journal of the National Cancer Institute·Ellen T ChangMads Melbye
Oct 14, 2004·Virchows Archiv : an International Journal of Pathology·Eva GeissingerThomas Rüdiger
Aug 5, 2011·Leukemia & Lymphoma·Santiago Montes-MorenoMiguel Angel Piris
Feb 1, 2011·Leukemia & Lymphoma·Mary J NinanPankaj Gupta
Jul 7, 2009·Hematology/oncology Clinics of North America·Laurence de Leval, Robert Paul Hasserjian
Apr 5, 2003·Pathology International·Naoya Nakamura, Masafumi Abe
Sep 2, 2008·Seminars in Hematology·John P LeonardRebecca Elstrom
Jul 16, 2008·Radiologic Clinics of North America·Matthew J Matasar, Andrew D Zelenetz
Mar 8, 2005·Blood Reviews·Maher K Gandhi, Robert E Marcus
Feb 8, 2005·Best Practice & Research. Clinical Haematology·Shaklai SigalGideon Rechavi
Nov 30, 2010·Best Practice & Research. Clinical Haematology·Edward D Ball, H Elizabeth Broome
Aug 9, 2005·Hematology/oncology Clinics of North America·Silvia Montoto, T Andrew Lister
Jul 12, 2008·Cancer Genetics and Cytogenetics·L Goldberg-BittmanA Amiel
Sep 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pascale De PaepeChris De Wolf-Peeters
Aug 8, 2019·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Neha SinghAnurag Mehta
May 7, 2021·Journal of Medical Case Reports·Sawsan IsmailZuheir Alshehabi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.